Levosimendan pre-treatment in patients undergoing coronary artery bypass graft surgery: a double-blind, single center, prospective, randomized, placebo-controlled trial

Trial Profile

Levosimendan pre-treatment in patients undergoing coronary artery bypass graft surgery: a double-blind, single center, prospective, randomized, placebo-controlled trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Feb 2009

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Coronary artery disease; Myocardial ischaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top